Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery

Stem Cells

Volumn 27, Issue 5, 2009, Pages 1077-1087

  Orbán, Tamás I ^a   Apáti, Ágota ^a   Németh, Andrea ^a   Varga, Nóra ^a   Krizsik, Virág ^a   Schamberger, Anita ^a   Szebényi, Kornélia ^a   Erdei, Zsuzsa ^a   Várady, György ^a   Karászi, Éva ^a   Homolya, László ^a   Német, Katalin ^a   Gócza, Elen ^b   Miskey, Csaba ^c   Mátés, Lajos ^c   Ivics, Zoltán ^c   Izsvák, Zsuzsanna ^c   Sarkadi, Balázs ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

"Double feature" promoter; CAG promoter; Cardiomyocytes; Human embryonic stem cells; Lentiviral gene delivery; Sleeping beauty transposon

Indexed keywords

ACTIN; CYTOMEGALOVIRUS ACTIN GLOBIN; ELONGATION FACTOR 1ALPHA; ENHACED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PHOSPHOGLYCERATE KINASE; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DUPLICATE GENE; EMBRYONIC STEM CELL; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE NUMBER; GENE SEQUENCE; GENE TARGETING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTEGRATION; MOLECULAR CLONING; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENE; TRANSPOSON;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CLONE CELLS; COMPUTATIONAL BIOLOGY; DNA TRANSPOSABLE ELEMENTS; EMBRYONIC STEM CELLS; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TRANSGENES;

EID: 66149170086     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.45     Document Type: Article

References (42)

1. Schroder AR, Shinn P, Chen H et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002;110:521-529. (Pubitemid 35232295)
2. VandenDriessche T, Collen D, Chuah MK. Biosafety of onco-retroviral vectors. Curr Gene Ther 2003;3:501-515.
3. Ivics Z, Izsvak Z. Transposons for gene therapy! Curr Gene Ther 2006;6:593-607.
4. Izsvak Z, Ivics Z. Sleeping beauty transposition: Biology and applications for molecular therapy. Mol Ther 2004;9:147-156. (Pubitemid 38256540)
5. Izsvak Z, Ivics Z, Plasterk RH. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 2000;302:93-102.
6. Ivics Z, Izsvak Z. Transposable elements for transgenesis and insertional mutagenesis in vertebrates: A contemporary review of experimental strategies. Methods Mol Biol 2004;260:255-276.
7. Lev S, Kehat I, Gepstein L. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 2005;1047:50-65. (Pubitemid 41123827)
8. Karner E, Unger C, Sloan AJ et al. Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev 2007;16:39-52. (Pubitemid 46362591)
9. Chen K, Wu L, Wang ZZ. Extrinsic regulation of cardiomyocyte differentiation of embryonic stem cells. J Cell Biochem 2008;104:119-128.
10. Tomescot A, Leschik J, Bellamy V et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 2007;25:2200-2205. (Pubitemid 47480478)
11. Passier R, Oostwaard DW, Snapper J et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 2005;23:772-780. (Pubitemid 40791792)
12. Kolossov E, Bostani T, Roell W et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006;203:2315-2327. (Pubitemid 44498366)
13. Huber I, Itzhaki I, Caspi O et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 2007;21:2551-2563. (Pubitemid 47230684)
14. Duan Y, Catana A, Meng Y et al. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 2007;25:3058-3068. (Pubitemid 350294431)
15. Gallo P, Grimaldi S, Latronico MV et al. A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells. Gene Ther 2008;15:161-170.
16. Ward CM, Stern PL. The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells. Stem Cells 2002;20:472-475.
17. Zeng X, Chen J, Sanchez JF et al. Stable expression of hrGFP by mouse embryonic stem cells: Promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells 2003;21:647-653. (Pubitemid 37329157)
18. Krishnan M, Park JM, Cao F et al. Effects of epigenetic modulation on reporter gene expression: Implications for stem cell imaging. FASEB J 2006;20:106-108. (Pubitemid 43100482)
19. Liew CG, Draper JS, Walsh J et al. Transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007;25:1521-1528.
20. Chung S, Andersson T, Sonntag KC et al. Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells 2002;20:139-145. (Pubitemid 34297261)
21. Xia X, Zhang Y, Zieth CR et al. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev 2007;16:167-176. (Pubitemid 46362600)
22. Ivics Z, Hackett PB, Plasterk RH et al. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997;91:501-510. (Pubitemid 27508239)
23. Apati A, Orban TI, Varga N et al. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700-2709.
24. Ivics Z, Katzer A, Stuwe EE et al. Targeted Sleeping Beauty transposition in human cells. Mol Ther 2007;15:1137-1144. (Pubitemid 46813616)
25. Vigdal TJ, Kaufman CD, Izsvak Z et al. Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol 2002;323:441-452. (Pubitemid 35283672)
26. Schambach A, Galla M, Maetzig T et al. Improving transcriptional termination of self-inactivating γ-retroviral and lentiviral vectors. Mol Ther 2007;15:1167-1173. (Pubitemid 46813620)
27. Ujhelly O, Ozvegy C, Varady G et al. Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells. Hum Gene Ther 2003;14:403-412. (Pubitemid 36308359)
28. Schulz TC, Palmarini GM, Noggle SA et al. Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci 2003;4:27.
29. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147. (Pubitemid 28516247)
30. Capi O, Gepstein L. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. J Control Release 2006;116:211-218.
31. Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414. (Pubitemid 32730787)
32. Xu C, Police S, Rao N et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-508.
33. Wilber A, Linehan JL, Tian X et al. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 2007;25:2919-2927. (Pubitemid 350127877)
34. Chan KK, Wu SM, Nissom PM et al. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 α promoter system. Stem Cells Dev 2008;17:825-836.
35. Chen CY, Schwartz RJ. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac α-actin gene transcription. Mol Cell Biol 1996;16:6372-6384. (Pubitemid 26360996)
36. Sepulveda JL, Belaguli N, Nigam V et al. GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: Role for regulating early cardiac gene expression. Mol Cell Biol 1998;18:3405-3415. (Pubitemid 28240513)
37. Christoforou N, Miller RA, Hill CM et al. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest 2008;118:894-903.
38. Linhares VL, Almeida NA, Menezes DC et al. Transcriptional regulation of the murine Connexin40 promoter by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc Res 2004;64:402-411. (Pubitemid 39505419)
39. Wang D, Chang PS, Wang Z et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001;105:851-862. (Pubitemid 32635087)
40. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-199.
41. Sawicki JA, Morris RJ, Monks B et al. A composite CMV-IE enhancer/β-actin promoter is ubiquitously expressed in mouse cutaneous epithelium. Exp Cell Res 1998;244:367-369. (Pubitemid 28480885)
42. Xu ZL, Mizuguchi H, Ishii-Watabe A et al. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 2001;272:149-156. (Pubitemid 32695407)